ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $630,000 | -48.5% | 10,000 | -62.9% | 0.00% | -66.7% |
| Q4 2019 | $1,224,000 | -5.8% | 26,943 | -5.1% | 0.01% | -25.0% |
| Q3 2019 | $1,300,000 | -15.7% | 28,392 | +7.9% | 0.01% | -20.0% |
| Q2 2019 | $1,543,000 | +15.2% | 26,324 | -11.8% | 0.01% | +25.0% |
| Q1 2019 | $1,339,000 | +9.5% | 29,850 | -4.9% | 0.01% | +14.3% |
| Q4 2018 | $1,223,000 | -7.1% | 31,401 | +9.7% | 0.01% | +40.0% |
| Q3 2018 | $1,317,000 | – | 28,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |